The scale of the analysis is what sets the work apart. Single-cell RNA sequencing allows researchers to read the gene-expression fingerprint of thousands of individual cells, but combining datasets across laboratories, species of injury models and disease states is a formidable computational challenge. The team integrated, clustered and annotated the full complement of 236,748 fibroblasts, then applied a battery of analytical tools: differential gene-expression testing to compare healthy and fibrotic states, RNA velocity to infer the direction of cellular transitions, and non-negative matrix factorization, or NMF, to decompose the transcriptional landscape into coherent gene-expression programs that recur across cells and samples.

The clustering revealed eight major populations of cardiac fibroblasts, which the researchers organized into two broad lineages. One lineage, which they termed the steady-state lineage, corresponds to the fibroblasts that maintain the structural scaffolding of the healthy heart. The second, the fibrotic-state lineage, encompasses the activated cells that expand after injury and drive pathological remodeling. This two-lineage framework gives the field a vocabulary for what has been a confusing picture: fibroblasts in a scarred heart are not simply more numerous versions of their healthy counterparts, but a collection of distinct cell states with different gene-expression signatures and, presumably, different functions.

The NMF analysis added a second layer of insight by identifying twelve meta-programs, recurring modules of co-expressed genes that cut across individual cell clusters. Among these, one connection stood out: a strong association between PDK4-mediated glycolysis and extracellular matrix deposition. PDK4, pyruvate dehydrogenase kinase 4, is an enzyme that sits at a critical metabolic junction. By phosphorylating and inhibiting the pyruvate dehydrogenase complex, it blocks the flow of pyruvate into the mitochondria and the tricarboxylic acid cycle, pushing cells toward glycolysis and the conversion of pyruvate into lactate. The finding that this metabolic program tracks with matrix production in fibroblasts suggested, provocatively, that scarring might be fueled by a specific metabolic rewiring rather than being an incidental byproduct of inflammation.

To test that idea, the researchers turned to neonatal mouse primary cardiac fibroblasts grown in the laboratory, and deployed a series of mechanistic experiments: immunoblotting to measure protein levels, metabolomics to profile metabolic intermediates, co-immunoprecipitation to detect protein interactions, and ChIP-qPCR to examine binding to chromatin. The results traced a complete signaling chain. PDK4 activity promoted the production of lactate, the metabolic end-product that accumulates when cells rely heavily on glycolysis. That lactate, in turn, drove histone H3 lactylation, a chemical modification in which lactate-derived lactyl groups are attached to histone proteins, the spools around which DNA is wound.

Histone lactylation is a relatively recent addition to the catalog of epigenetic marks, first described as a link between cellular metabolism and gene regulation. By modifying histones, lactate does not merely accumulate as waste; it can actively reshape which genes are accessible for transcription. In the fibroblasts studied here, histone H3 lactylation increased the expression of TGF-β1, transforming growth factor beta 1, the canonical profibrotic cytokine that activates fibroblasts and stimulates them to synthesize collagen and other extracellular matrix components. The chain from PDK4 to glycolysis to lactate to histone lactylation to TGF-β1 to matrix synthesis therefore constitutes a coherent mechanistic model in which a metabolic enzyme acts upstream of the central molecular driver of fibrosis.

The critical question, of course, is whether interrupting this chain in a living animal can protect the heart. The researchers addressed this in a mouse model of myocardial infarction, in which the left anterior descending coronary artery is ligated to reproduce the ischemic injury of a human heart attack. Using immunofluorescence, flow cytometry and echocardiography, they evaluated what happened when PDK4 was inhibited. The outcome was striking: blocking PDK4 alleviated cardiac fibrosis and improved cardiac function in the infarcted mice. The team also demonstrated antifibrotic effects from fibroblast-targeted PDK4 knockdown delivered by AAV9, an adeno-associated viral vector commonly used to shuttle genetic payloads into cardiac tissue, which strengthens the case that the benefit arises from acting on fibroblasts specifically rather than through indirect effects on other cell types.

These findings arrive at a moment when the metabolic control of immune and stromal cells is one of the fastest-moving areas of biology. The idea that lactate is not a dead-end metabolite but a signaling molecule capable of reprogramming gene expression has transformed how researchers think about tumors, inflammation and now fibrosis. The new study extends that framework to the heart and, importantly, connects it to a druggable target. Kinases such as PDK4 are among the most tractable enzyme classes for pharmacological inhibition, and the demonstration that PDK4 inhibition improves cardiac function after infarction in mice provides a concrete proof of concept for a therapeutic strategy that would not merely slow scarring but intervene at its metabolic source.

The single-cell atlas itself is likely to prove as valuable as the mechanistic discovery. With eight fibroblast populations, two lineages and twelve meta-programs catalogued across healthy and diseased hearts, the resource gives investigators a reference against which future studies can map their own data, identify which fibroblast states expand in particular disease contexts and design experiments that target specific subpopulations rather than fibroblasts in general. The heterogeneity that once frustrated mechanistic understanding becomes, in this framing, a map of opportunities: if only a subset of fibroblast states drives pathological matrix deposition, therapies can be aimed at those states while sparing the cells that maintain normal cardiac architecture.

Cautions remain, as they always do in translational research. The mechanistic experiments were performed largely in neonatal mouse fibroblasts and mouse models of infarction, and human cardiac fibrosis involves additional layers of comorbidity, age and medication exposure that animal models only approximate. The published version of the paper was still subject to final editorial processing at the time of its early release, and the field will want to see the findings replicated independently. Nevertheless, the study delivers something rare: a large-scale descriptive atlas, a specific molecular mechanism and an in vivo therapeutic validation, all pointing at the same target. If PDK4-driven lactylation of histones proves as central to human cardiac fibrosis as it appears to be in the mouse, the enzyme that once seemed an obscure regulator of mitochondrial fuel choice may become one of the most closely watched targets in cardiovascular medicine.

Subject of Research: Fibroblast heterogeneity and PDK4-driven metabolic activation in cardiac fibrosis after myocardial infarction

Article Title: Single-cell transcriptomics landscape decodes cardiac fibroblast heterogeneity and reveals PDK4-driven profibrotic activation during cardiac fibrosis

Article References: Qi, X., Guo, S., Sun, Y., Zhang, L., Lu, K., Huang, X., Tang, R., Zhang, N., Yu, D., & Lian, F. (2026). Single-cell transcriptomics landscape decodes cardiac fibroblast heterogeneity and reveals PDK4-driven profibrotic activation during cardiac fibrosis. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-08985-3

Image Credits: AI Generated

DOI: 10.1186/s12967-026-08985-3

Keywords: cardiac fibroblasts, single-cell transcriptomics, myocardial fibrosis, PDK4, histone lactylation, lactate, TGF-β1, extracellular matrix, myocardial infarction, glycolysis, AAV9, non-negative matrix factorization

The research team began by asking a fundamental question about the egg itself. Oocytes, the precursors of eggs, carry their own DNA methylome, a landscape of methyl groups attached to cytosine bases that helps regulate which genes are active. When the researchers compared oocytes from mice fed a high-fat diet with oocytes from normally fed mice, they found nearly 940 differentially methylated regions, many of them sitting at genes with well-established roles in metabolism. Crucially, the changes were not random noise scattered across the genome. They clustered at specific regulatory loci, including regions controlling Hnf1α, a transcription factor that governs liver and pancreatic gene programs; Thra, encoding a thyroid hormone receptor involved in hepatic insulin sensitivity; and Pdk4, a kinase that suppresses glucose oxidation in favor of fat burning. These were precisely the kinds of genes whose misregulation could plausibly produce the metabolic phenotypes seen in offspring of obese mothers.

The next question was whether these methylation changes actually persist into the next generation, and here the study produced some of its most surprising findings. Embryos are known to undergo dramatic epigenetic reprogramming: shortly after fertilization, most DNA methylation across the genome is erased and then rebuilt anew, a process thought to wipe the slate clean between generations. The team tracked the methylation status of the obesity-associated regions through blastocysts, primordial germ cells and the tissues of first- and second-generation offspring. The methylation marks themselves were indeed erased during embryogenesis, exactly as the textbooks predict. Yet the genes did not return to normal. Hnf1α, Thra and Pdk4 showed persistent transcriptional dysregulation across two generations, and the methylation patterns re-emerged at the same loci in the germline of the next generation of females, suggesting that something other than the methyl marks themselves was carrying the memory forward.

That something, the researchers discovered, appears to be a histone modification. At the affected loci, enrichment of H3K36me2, a chemical tag on histone proteins that is known to recruit the de novo DNA methyltransferases in oocytes, was retained even after the DNA methylation had been stripped away. In other words, the embryo erased the methyl letters but kept the highlighted page. When the oocytes of the next generation were formed, the H3K36me2 signal guided the methylation machinery back to the same spots, re-establishing the aberrant pattern. This chromatin-based bookmark offers a mechanistic explanation for how environmental information can tunnel through the reprogramming barrier, and it aligns with earlier work showing that H3K36me2 and its trimerized cousin H3K36me3 form a platform essential for DNA methylation establishment in mouse oocytes.

To connect specific methylation changes to specific metabolic outcomes, the team turned to an elegant set of experiments using methylation editing. Rather than relying on diet to produce diffuse, genome-wide changes, they injected in vitro-matured oocytes with a catalytically dead Cas9 fused to the methyltransferase Dnmt3a, together with guide RNAs targeting single differentially methylated regions. This allowed them to hypermethylate one locus at a time and ask what each mark does on its own. The results were remarkably clean. Offspring derived from oocytes with targeted hypermethylation at the Hnf1α region showed enhanced hepatic gluconeogenesis, meaning their livers produced more glucose, while offspring with engineered hypermethylation at the Pdk4 region displayed impaired glucose tolerance. Both effects were female-biased, echoing the sex-specific patterns seen in the diet-induced model, and both persisted into the second generation when the edited females were bred onward.

The sex specificity is itself an important clue. Female offspring carried the metabolic consequences far more prominently than males, and methylation analyses across liver, kidney, brain and muscle showed that the aberrant marks were established in a tissue-specific pattern rather than uniformly across the body. The researchers also found that single CpG sites within the differentially methylated regions acted as regulatory landmarks correlating with gene expression, providing fine-grained markers that could eventually be used to read the epigenetic state of a locus without sequencing entire regions. This level of resolution matters because it moves the field from correlational observations, where obese mothers tend to have affected offspring, toward a causal, mechanistic account in which defined chemical marks at defined genes produce defined phenotypes.

Perhaps the most consequential finding for human medicine came when the team examined oocytes donated by women undergoing fertility treatment. In oocytes from women with obesity, the researchers detected conserved hypermethylation at the same HNF1A and THRA loci that had been flagged in the mouse studies. The convergence is striking: two species separated by tens of millions of years of evolution, exposed to obesity through very different diets and environments, show methylation changes at homologous metabolic genes. While the human sample cannot prove causation, the conservation of the pattern strongly suggests that the mechanism identified in mice is not a laboratory artifact but a feature of mammalian biology that operates in people.

The study builds on a growing body of evidence that the germline is a conduit for environmental memory. Earlier work has shown that sperm carry small RNAs that transmit acquired metabolic disorders to offspring, that paternal diet shapes offspring chromatin states, and that oocyte deficiencies in factors such as Stella and TET3 can transmit glucose intolerance from obese mothers to their young. What distinguishes the new research is its combination of genome-wide mapping across generations, identification of a chromatin-based persistence mechanism, and direct causal demonstration through targeted methylation editing. Together these threads turn a suggestive correlation into a coherent causal chain: maternal obesity alters the oocyte methylome at metabolic loci, H3K36me2 bookmarks those loci through embryonic reprogramming, methylation is re-established in the next generation’s germline, and the resulting gene dysregulation produces measurable metabolic dysfunction in offspring, preferentially in females.

The implications reach well beyond the laboratory. If the preconception oocyte is the critical window during which these marks are laid down, then interventions aimed at improving metabolic health before pregnancy, rather than during it, may carry particular weight for breaking the intergenerational cycle of obesity and diabetes. The finding that methylation marks are erased but re-established also suggests potential targets: if the H3K36me2 bookmarking step could be understood in finer detail, it might eventually become possible to interrupt the re-establishment of pathological marks without touching the normal reprogramming program. The authors caution that much work remains, including determining how broadly the mechanism applies across loci and confirming the human findings at scale. But the central message is already clear and, for a condition affecting hundreds of millions of people worldwide, sobering: the metabolic consequences of obesity can be written into the egg itself, in the language of DNA methylation, and read out again in the bodies of children and grandchildren.

Subject of Research: Intergenerational epigenetic inheritance of metabolic dysfunction via oocyte DNA methylation in maternal obesity

Article Title: Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction

Article References: Han, L., Wu, Y., Li, J., Chen, Y., Li, L., Wang, T., Chen, M., Wang, S., Li, C., Ding, G., Li, J., Sun, H., Shi, Z., & Wang, Q. (2026). Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction. Nature Metabolism. https://doi.org/10.1038/s42255-026-01617-6

Image Credits: AI Generated

DOI: 10.1038/s42255-026-01617-6

Keywords: maternal obesity, oocytes, DNA methylation, epigenetic inheritance, H3K36me2, Hnf1α, Pdk4, Thra, glucose metabolism, methylation editing, Nature Metabolism, intergenerational metabolic dysfunction

Growth hormone, secreted by the pituitary gland, has long been known to influence lifespan. Mice engineered to lack the receptor everywhere in the body are dwarfs, but they are also the longest-lived laboratory mouse strain ever recorded, with enhanced insulin sensitivity and resistance to obesity-driven inflammation. Recent work has refined this picture by deleting the receptor in individual tissues. Removing it from fat cells modestly extends lifespan and improves frailty and cognition in aged mice, while removing it from the liver was previously shown to trigger fat-producing genetic programs and pathological lipid buildup. What remained unclear was whether hepatic growth hormone signaling influences aging itself rather than just metabolism.

To answer that question, the team crossed mice carrying floxed GHR alleles with Albumin-Cre transgenic animals, producing offspring in which the receptor was excised exclusively in hepatocytes. Polymerase chain reaction confirmed that the deletion was confined to the liver and absent from fat, heart, spleen, kidney, lung, brain, and intestine. The researchers then followed cohorts of male and female knockout and control mice for up to two years, feeding some a standard chow diet and others a high-fat diet to test whether metabolic stress would amplify any aging phenotype.

The results in males were dramatic. Survival curves showed that male LiGHR knockout mice died significantly earlier than controls, while females showed no significant difference, hinting at a sex-dependent effect. At 24 months of age, the knockout males weighed less, had sparser fur, and performed worse across a battery of behavioral tests. In the Y-maze, they spent less time exploring a novel arm of the maze; in the Morris water maze, they took longer to find a hidden platform and crossed its former location fewer times; and in the open field test, they traveled shorter distances in the central zone. Together, these assays indicated genuine deficits in spatial learning and memory rather than simple locomotor impairment.

The systemic picture was equally troubling. Serum levels of the proinflammatory cytokines tumor necrosis factor alpha, interleukin-6, and interleukin-1 beta were all elevated, a signature of the chronic low-grade inflammation often called inflammaging. Blood triglycerides and total cholesterol were increased. Micro-computed tomography of the right femur revealed reduced bone mineral density, lower bone volume fraction, and thinner trabeculae, hallmarks of musculoskeletal frailty. Glucose tolerance and insulin tolerance tests showed impaired metabolic resilience. The authors are careful to note an important caveat: because deleting hepatic GHR disrupts the normal feedback loop and raises circulating growth hormone, other tissues with intact receptors are bathed in excess hormone. The model therefore cannot fully separate liver-intrinsic effects from indirect effects of elevated growth hormone acting on fat, muscle, bone, and brain, and the team suggests inducible or reversible knockout strategies to resolve this in future work.

Inside the liver itself, the evidence of accelerated aging was unambiguous. Senescence-associated beta-galactosidase activity was markedly elevated, and the classic senescence markers p16, p21, and p53 were upregulated, along with gamma-H2AX, a marker of DNA damage. Masson’s trichrome staining revealed fibrotic scarring, alpha-SMA and collagen levels rose, and Oil Red O staining showed extensive lipid droplet accumulation. Hepatic triglyceride and cholesterol content climbed with age. A parallel experiment in young adult mice fed a high-fat diet for three months reproduced the pattern: more steatosis, more senescence markers, more fibrosis, worse liver enzymes, and dyslipidemia compared with diet-stressed controls. When the researchers compared 12-month-old knockout mice on chow versus those previously fed a high-fat diet, the diet group showed greater lipid accumulation and higher expression of senescence and inflammatory proteins, supporting a mechanistic link between ectopic lipid deposition and accelerated hepatic aging. In cell culture, knocking down GHR in AML12 hepatocyte-like cells and challenging them with a mixture of oleate and palmitate for a week synergistically increased senescence markers, lipid droplets, and inflammatory gene expression.

The mechanistic trail began in the fat. Because hepatic GHR loss disrupts the growth hormone feedback axis, the knockout mice had elevated serum growth hormone and reduced IGF1. Growth hormone is a potent lipolytic signal, and indeed the subcutaneous and epididymal fat depots of the knockout males were shrunken, with fewer and smaller lipid droplets. Lipolysis proteins including ATGL, HSL, and MGLL were upregulated in fat tissue, the thermogenic marker UCP1 increased, and serum non-esterified fatty acids rose. The liver, meanwhile, ramped up expression of CD36, the fatty acid transporter, providing a doorway for the flood of liberated fat to enter hepatocytes. The result was a perfect storm: fat exported from adipose tissue, actively imported by the liver, and deposited as ectopic lipid that feeds back into senescence and inflammation.

RNA sequencing of liver tissue pinpointed the signaling cascade behind this cascade of damage. Loss of GHR signaling reduced phosphorylation of the transcription factor STAT5b, which normally suppresses the nuclear receptor PPAR gamma. With that brake released, PPAR gamma expression and nuclear translocation increased, and cross-referencing its known target genes with the transcriptomic data highlighted CD36 and, most strikingly, PDK4, whose messenger RNA rose more than sevenfold. Dual-luciferase reporter assays in HEK293T cells confirmed that PPAR gamma directly activates the PDK4 promoter, and mutating the predicted binding motif abolished this activation. Overexpressing STAT5b in AML12 cells lowered both PPAR gamma and PDK4, while silencing PPAR gamma with small interfering RNAs reduced PDK4, cementing a GH-GHR-STAT5b-PPAR gamma-PDK4 axis. Additional pathway analysis showed reduced AMPK phosphorylation and SIRT1 alongside increased mTOR and NF-kappa B activity, indicating that multiple aging-related signaling networks were simultaneously deranged.

PDK4, pyruvate dehydrogenase kinase 4, is a mitochondrial enzyme that throttles glucose oxidation by inhibiting the pyruvate dehydrogenase complex, and it has previously been implicated in fatty liver disease, insulin resistance, and vascular calcification. In the knockout livers, reactive oxygen species accumulated, antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase declined, and transmission electron microscopy revealed mitochondria with ruptured membranes and disorganized cristae. Autophagy markers shifted in a pattern consistent with cellular stress. In cultured cells, Seahorse extracellular flux analysis showed that GHR knockdown plus free fatty acid treatment synergistically suppressed basal respiration, maximal respiratory capacity, ATP production, and spare respiratory capacity, while Mito-Tracker staining exposed grossly abnormal mitochondrial morphology. Lipid overload and mitochondrial failure thus formed a self-reinforcing pathological loop.

The therapeutic payoff came from a PDK4-specific inhibitor. Starting at 20 months of age, the researchers treated knockout and control mice weekly for 16 weeks with the compound at low and high doses. PDK4 levels fell, serum liver enzymes ALT and AST dropped, hepatic fat accumulation diminished, and electron microscopy showed restored mitochondrial ultrastructure with reduced reactive oxygen species. Inflammatory cytokines in blood and liver declined in a dose-dependent manner, fibrosis eased, and the senescence markers p16, p21, and gamma-H2AX were downregulated. Encouragingly, the inhibitor also reduced senescence and inflammation markers in naturally aged control mice, echoing earlier reports that late-life PDK4 inhibition extends median lifespan in aged animals. The authors conclude that hepatic growth hormone receptor signaling, acting through the STAT5b-PPAR gamma-PDK4 axis, is a meaningful contributor to liver aging and a promising target for interventions aimed at extending healthspan, though they caution that the systemic phenotypes likely reflect combined liver-intrinsic and hormone-driven effects that future inducible models will need to disentangle.

Subject of Research: Hepatocyte-specific growth hormone receptor deletion, hepatic mitochondrial dysfunction, and accelerated aging in mice

Article Title: Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction

Article References: Yang, K., Jian, Y., Pang, F., Ying, M., Yang, Q., Liu, N., Wang, S., & Wu, Y. (2026). Hepatocyte Growth Hormone Receptor Ablation Is Associated With Aging Phenotypes and Hepatic Mitochondrial Dysfunction. Aging Cell, 25(10), Article e70741. https://doi.org/10.1111/acel.70741

Image Credits: AI Generated

DOI: 10.1111/acel.70741

Keywords: aging, growth hormone receptor, liver, mitochondrial dysfunction, PDK4, PPAR gamma, STAT5b, hepatic steatosis, cellular senescence, inflammaging, knockout mice, lipid metabolism